Market Tracker

02/17 5:16pm ET

Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

15.00
Delayed Data
As of Feb 17
 +0.50 / +3.45%
Today’s Change
6.95
Today|||52-Week Range
18.00
-5.96%
Year-to-Date
No recent news for Vanda Pharmaceuticals Inc.

Today’s Trading

Previous close14.50
Today’s open14.60
Day’s range14.45 - 15.30
Volume1,160,968
Average volume (3 months)601,157
Market cap$659.2M
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+56.38%
Earnings growth (this year)--
Earnings growth (next 5 years)+19.10%
Revenue growth (last year)+32.83%
P/E ratioNM
Price/Sales4.75
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ARDXArdelyx Inc-0.10-0.76%
ACIUAC Immune Ltd-0.01-0.08%
FLXNFlexion Therapeutics...-0.05-0.26%
RVNCRevance Therapeutics...-0.25-1.18%
Data as of 4:00pm ET, 02/17/2017

Financials

Last reporting dateFebruary 16, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$146.0M
Annual profit (last year)-$18.0M
Net profit margin-12.33%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mihael Hristos Polymeropoulos
Chief Financial Officer, Treasurer &
Senior VP
James Patrick Kelly
Corporate headquarters
Washington, District Of Columbia

Forecasts